{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:58:33Z","timestamp":1790524713067,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T00:00:00Z","timestamp":1585526400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T00:00:00Z","timestamp":1585526400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s12098-020-03252-9","type":"journal-article","created":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T20:03:51Z","timestamp":1585598631000},"page":"633-640","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Current Perspectives in Management of Edema in Nephrotic Syndrome"],"prefix":"10.1007","volume":"87","author":[{"given":"Jitendra","family":"Meena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvind","family":"Bagga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,30]]},"reference":[{"key":"3252_CR1","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/0002-9343(52)90020-X","volume":"13","author":"AA Epstein","year":"1952","unstructured":"Epstein AA. Concerning the causation of edema in chronic parenchymatous nephritis: method for its alleviation. Am J Med. 1952;13:556\u201361.","journal-title":"Am J Med"},{"key":"3252_CR2","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/0002-9343(79)90782-4","volume":"67","author":"EJ Dorhout","year":"1979","unstructured":"Dorhout EJ, Roos JC, Boer P, Yoe OH, Simatupang TA. Observations on edema formation in the nephrotic syndrome in adults with minimal lesions. Am J Med. 1979;67:378\u201384.","journal-title":"Am J Med"},{"key":"3252_CR3","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/ki.2012.180","volume":"82","author":"EC Siddall","year":"2012","unstructured":"Siddall EC, Radhakrishnan J. The pathophysiology of edema formation in the nephrotic syndrome. Kidney Int. 2012;82:635\u201342.","journal-title":"Kidney Int"},{"key":"3252_CR4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3389\/fped.2015.00111","volume":"3","author":"D Ellis","year":"2016","unstructured":"Ellis D. Pathophysiology, evaluation, and management of edema in childhood nephrotic syndrome. Front Pediatr. 2016;3:111.","journal-title":"Front Pediatr"},{"key":"3252_CR5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000183206","volume":"37","author":"EA Brown","year":"1984","unstructured":"Brown EA, Markandu ND, Sagnella GA, Jones BE, MacGregor GA. Lack of effect of captopril on the sodium retention of the nephrotic syndrome. Nephron. 1984;37:43\u20138.","journal-title":"Nephron."},{"key":"3252_CR6","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/ki.1984.34","volume":"25","author":"M Usberti","year":"1984","unstructured":"Usberti M, Federico S, Meccariello S, et al. Role of plasma vasopressin in the impairment of water excretion in nephrotic syndrome. Kidney Int. 1984;25:422\u20139.","journal-title":"Kidney Int"},{"key":"3252_CR7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4103\/0971-4065.41289","volume":"18","author":"A Bagga","year":"2008","unstructured":"Bagga A. Revised guidelines for management of steroid-sensitive nephrotic syndrome. Indian J Nephrol. 2008;18:31\u20139.","journal-title":"Indian J Nephrol."},{"key":"3252_CR8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13052-017-0356-x","volume":"43","author":"A Pasini","year":"2017","unstructured":"Pasini A, Benetti E, Conti G, et al. The Italian Society for Pediatric Nephrology (SINePe) consensus document on the management of nephrotic syndrome in children: part I - diagnosis and treatment of the first episode and the first relapse. Ital J Pediatr. 2017;43:41.","journal-title":"Ital J Pediatr"},{"key":"3252_CR9","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/S0140-6736(82)90102-7","volume":"2","author":"EA Brown","year":"1982","unstructured":"Brown EA, Markandu ND, Sagnella GA, Squires M, Jones BE, MacGregor GA. Evidence that some mechanism other than the renin system causes sodium retention in nephrotic syndrome. Lancet. 1982;2:1237\u201340.","journal-title":"Lancet."},{"key":"3252_CR10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000168800","volume":"15","author":"M Usberti","year":"1995","unstructured":"Usberti M, Gazzotti RM, Poiesi C, D\u2019Avanzo L, Ghielmi S. Considerations on the sodium retention in nephrotic syndrome. Am J Nephrol. 1995;15:38\u201347.","journal-title":"Am J Nephrol"},{"key":"3252_CR11","doi-asserted-by":"crossref","first-page":"688","DOI":"10.7326\/0003-4819-91-5-688","volume":"91","author":"JI Meltzer","year":"1979","unstructured":"Meltzer JI, Keim HJ, Laragh JH, Sealey JE, Jan KM, Chien S. Nephrotic syndrome: vasoconstriction and hypervolemic types indicated by renin-sodium profiling. Ann Intern Med. 1979;91:688\u201396.","journal-title":"Ann Intern Med"},{"key":"3252_CR12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.kint.2017.07.023","volume":"93","author":"BN Bohnert","year":"2018","unstructured":"Bohnert BN, Menacher M, Janessa A, et al. Aprotinin prevents proteolytic epithelial sodium channel (ENaC) activation and volume retention in nephrotic syndrome. Kidney Int. 2018;93:159\u201372.","journal-title":"Kidney Int"},{"key":"3252_CR13","doi-asserted-by":"crossref","first-page":"F235","DOI":"10.1152\/ajprenal.00138.2015","volume":"309","author":"M St\u00e6hr","year":"2015","unstructured":"St\u00e6hr M, Buhl KB, Andersen RF, et al. Aberrant glomerular filtration of urokinase-type plasminogen activator in nephrotic syndrome leads to amiloride-sensitive plasminogen activation in urine. Am J Physiol Renal Physiol. 2015;309:F235\u201341.","journal-title":"Am J Physiol Renal Physiol"},{"key":"3252_CR14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/MNH.0b013e3283330fb2","volume":"19","author":"CJ Passero","year":"2010","unstructured":"Passero CJ, Hughey RP, Kleyman TR. New role for plasmin in sodium homeostasis. Curr Opin Nephrol Hypertens. 2010;19:13\u20139.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"3252_CR15","doi-asserted-by":"crossref","first-page":"37073","DOI":"10.1074\/jbc.M307003200","volume":"278","author":"RP Hughey","year":"2003","unstructured":"Hughey RP, Mueller GM, Bruns JB, et al. Maturation of the epithelial Na+ channel involves proteolytic processing of the alpha- and gamma-subunits. J Biol Chem. 2003;278:37073\u201382.","journal-title":"J Biol Chem"},{"key":"3252_CR16","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1681\/ASN.2008040364","volume":"20","author":"P Svenningsen","year":"2009","unstructured":"Svenningsen P, Bistrup C, Friis UG, et al. Plasmin in nephrotic urine activates the epithelial sodium channel. J Am Soc Nephrol. 2009;20:299\u2013310.","journal-title":"J Am Soc Nephrol"},{"key":"3252_CR17","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000501059","volume":"50","author":"J-L Chen","year":"2019","unstructured":"Chen J-L, Wang L, Yao X-M, et al. Association of urinary plasminogen-plasmin with edema and epithelial sodium channel activation in patients with nephrotic syndrome. Am J Nephrol. 2019;50:92\u2013104.","journal-title":"Am J Nephrol"},{"key":"3252_CR18","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000045661","volume":"85","author":"G Rostoker","year":"2000","unstructured":"Rostoker G, Behar A, Lagrue G. Vascular hyperpermeability in nephrotic edema. Nephron. 2000;85:194\u2013200.","journal-title":"Nephron."},{"key":"3252_CR19","first-page":"73","volume":"23","author":"G Lagrue","year":"1975","unstructured":"Lagrue G, Branellec A, Blanc C, et al. A vascular permeability factor in lymphocyte culture supernants from patients with nephrotic syndrome. II. Pharmacological and physicochemical properties. Biomedicine. 1975;23:73\u20135.","journal-title":"Biomedicine."},{"key":"3252_CR20","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/ki.1984.176","volume":"26","author":"AB Geers","year":"1984","unstructured":"Geers AB, Koomans HA, Roos JC, Boer P, Dorhout Mees EJ. Functional relationships in the nephrotic syndrome. Kidney Int. 1984;26:324\u201330.","journal-title":"Kidney Int"},{"key":"3252_CR21","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1038\/ki.1996.207","volume":"49","author":"J Vande Walle","year":"1996","unstructured":"Vande Walle J, Donckerwolcke R, Boer P, van Isselt HW, Koomans HA, Joles JA. Blood volume, colloid osmotic pressure and F-cell ratio in children with the nephrotic syndrome. Kidney Int. 1996;49:1471\u20137.","journal-title":"Kidney Int"},{"key":"3252_CR22","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2215\/CJN.04390808","volume":"4","author":"G Kapur","year":"2009","unstructured":"Kapur G, Valentini RP, Imam AA, Mattoo TK. Treatment of severe edema in children with nephrotic syndrome with diuretics alone-a prospective study. Clin J Am Soc Nephrol. 2009;4:907\u201313.","journal-title":"Clin J Am Soc Nephrol"},{"key":"3252_CR23","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0140-6736(95)91210-X","volume":"346","author":"JG Vande Walle","year":"1995","unstructured":"Vande Walle JG, Donckerwolcke RA, van Isselt JW, Derkx FH, Joles JA, Koomans HA. Volume regulation in children with early relapse of minimal-change nephrosis with or without hypovolaemic symptoms. Lancet. 1995;346:148\u201352.","journal-title":"Lancet."},{"key":"3252_CR24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00431-017-3029-2","volume":"177","author":"W Keenswijk","year":"2018","unstructured":"Keenswijk W, Ilias MI, Raes A, Donckerwolcke R, Walle JV. Urinary potassium to urinary potassium plus sodium ratio can accurately identify hypovolemia in nephrotic syndrome: a provisional study. Eur J Pediatr. 2018;177:79\u201384.","journal-title":"Eur J Pediatr"},{"key":"3252_CR25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.5414\/CNP59259","volume":"59","author":"RA Donckerwolcke","year":"2003","unstructured":"Donckerwolcke RA, France A, Raes A, Vande WJ. Distal nephron sodium-potassium exchange in children with nephrotic syndrome. Clin Nephrol. 2003;59:259\u201366.","journal-title":"Clin Nephrol"},{"key":"3252_CR26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s004670000536","volume":"16","author":"O D\u00f6nmez","year":"2001","unstructured":"D\u00f6nmez O, Mir S, Ozy\u00fcrek R, Cura A, Kabasakal C. Inferior vena cava indices determine volume load in minimal lesion nephrotic syndrome. Pediatr Nephrol. 2001;16:251\u20135.","journal-title":"Pediatr Nephrol"},{"key":"3252_CR27","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ajem.2007.07.012","volume":"26","author":"W Kosiak","year":"2008","unstructured":"Kosiak W, Swieton D, Piskunowicz M. Sonographic inferior vena cava\/aorta diameter index, a new approach to the body fluid status assessment in children and young adults in emergency ultrasound--preliminary study. Am J Emerg Med. 2008;26:320\u20135.","journal-title":"Am J Emerg Med"},{"key":"3252_CR28","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.nefro.2017.04.003","volume":"38","author":"H Nalcacioglu","year":"2018","unstructured":"Nalcacioglu H, Ozkaya O, Baysal K, et al. The role of bioelectrical impedance analysis, NT-ProBNP and inferior vena cava sonography in the assessment of body fluid volume in children with nephrotic syndrome. Nefrologia. 2018;38:48\u201356.","journal-title":"Nefrologia."},{"key":"3252_CR29","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3906\/sag-1312-132","volume":"45","author":"K \u00d6zdemir","year":"2015","unstructured":"\u00d6zdemir K, Mir MS, Din\u00e7el N, et al. Bioimpedance for assessing volume status in children with nephrotic syndrome. Turk J Med Sci. 2015;45:339\u201344.","journal-title":"Turk J Med Sci"},{"key":"3252_CR30","unstructured":"Goodman LS, Brunton LL, Chabner B, Knollmann BC. Goodman & Gilman's Pharmacological Basis of Therapeutics, 14th ed. New York: McGraw-Hill; 2017."},{"key":"3252_CR31","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.2215\/CJN.09630818","volume":"14","author":"DH Ellison","year":"2019","unstructured":"Ellison DH. Clinical pharmacology in diuretic use. Clin J Am Soc Nephrol. 2019;14:1248\u201357.","journal-title":"Clin J Am Soc Nephrol"},{"key":"3252_CR32","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2165\/00003495-200767060-00002","volume":"67","author":"F Ali","year":"2007","unstructured":"Ali F, Guglin M, Vaitkevicius P, Ghali JK. Therapeutic potential of vasopressin receptor antagonists. Drugs. 2007;67:847\u201358.","journal-title":"Drugs."},{"key":"3252_CR33","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00467-013-2687-1","volume":"29","author":"M Shimizu","year":"2014","unstructured":"Shimizu M, Ishikawa S, Yachi Y, et al. Tolvaptan therapy for massive edema in a patient with nephrotic syndrome. Pediatr Nephrol. 2014;29:915\u20137.","journal-title":"Pediatr Nephrol"},{"key":"3252_CR34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4103\/ijn.IJN_358_18","volume":"30","author":"J Meena","year":"2020","unstructured":"Meena J, Sinha A, Hari P, Bagga A. Therapy with the combination of tolvaptan and furosemide for refractory edema in nephrotic syndrome. Indian J Nephrol. 2020;30:53\u20135.","journal-title":"Indian J Nephrol"},{"key":"3252_CR35","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1136\/bmj.310.6990.1333a","volume":"310","author":"DW Eadington","year":"1995","unstructured":"Eadington DW, Plant WD, Winney RJ. Albumin in the nephrotic syndrome. BMJ. 1995;310:1333.","journal-title":"BMJ."},{"key":"3252_CR36","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1046\/j.1523-1755.1999.00298.x","volume":"55","author":"D Fliser","year":"1999","unstructured":"Fliser D, Zurbr\u00fcggen I, Mutschler E, et al. Coadministration of albumin and furosemide in patients with the nephrotic syndrome. Kidney Int. 1999;55:629\u201334.","journal-title":"Kidney Int"},{"key":"3252_CR37","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/bmj.310.6973.162","volume":"310","author":"F Akcicek","year":"1995","unstructured":"Akcicek F, Yalniz T, Basci A, Ok E, Mees EJ. Diuretic effect of frusemide in patients with nephrotic syndrome: is it potentiated by intravenous albumin? BMJ. 1995;310:162\u20133.","journal-title":"BMJ."},{"key":"3252_CR38","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3346\/jkms.2001.16.4.448","volume":"16","author":"KY Na","year":"2001","unstructured":"Na KY, Han JS, Kim YS, et al. Does albumin preinfusion potentiate diuretic action of furosemide in patients with nephrotic syndrome? J Korean Med Sci. 2001;16:448\u201354.","journal-title":"J Korean Med Sci"},{"key":"3252_CR39","first-page":"471","volume":"22","author":"A Ghafari","year":"2011","unstructured":"Ghafari A, Mehdizadeh A, Alavi-Darazam I, Rahimi E, Kargar C, Sepehrvand N. Co-administration of albumin-furosemide in patients with the nephrotic syndrome. Saudi J Kidney Dis Transplant. 2011;22:471\u20135.","journal-title":"Saudi J Kidney Dis Transplant"},{"key":"3252_CR40","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1471-2369-13-92","volume":"13","author":"B Phakdeekitcharoen","year":"2012","unstructured":"Phakdeekitcharoen B, Boonyawat K. The added-up albumin enhances the diuretic effect of furosemide in patients with hypoalbuminemic chronic kidney disease: a randomized controlled study. BMC Nephrol. 2012;13:92.","journal-title":"BMC Nephrol"},{"key":"3252_CR41","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00467-008-1062-0","volume":"24","author":"R Dharmaraj","year":"2009","unstructured":"Dharmaraj R, Hari P, Bagga A. Randomized cross-over trial comparing albumin and frusemide infusions in nephrotic syndrome. Pediatr Nephrol. 2009;24:775\u201382.","journal-title":"Pediatr Nephrol"},{"key":"3252_CR42","first-page":"CD009692","volume":"7","author":"JJ Ho","year":"2019","unstructured":"Ho JJ, Adnan AS, Kueh YC, Ambak NJ, Van Rostenberghe H, Jummaat F. Human albumin infusion for treating oedema in people with nephrotic syndrome. Cochrane Database Syst Rev. 2019;7:CD009692.","journal-title":"Cochrane Database Syst Rev"},{"key":"3252_CR43","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1542\/peds.91.6.1142","volume":"91","author":"RM Haws","year":"1993","unstructured":"Haws RM, Baum M. Efficacy of albumin and diuretic therapy in children with nephrotic syndrome. Pediatrics. 1993;91:1142\u20136.","journal-title":"Pediatrics."},{"key":"3252_CR44","unstructured":"Liumbruno GM, Bennardello F, Lattanzio A, Piccoli P, Rossettias G; Italian Society of Transfusion Medicine and Immunohaematology (SIMTI). Recommendations for the use of albumin and immunoglobulins. Blood Transfus. 2009;7:216\u201334."},{"key":"3252_CR45","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s00467-015-3241-0","volume":"31","author":"J McCaffrey","year":"2016","unstructured":"McCaffrey J, Lennon R, Webb NJA. The non-immunosuppressive management of childhood nephrotic syndrome. Pediatr Nephrol. 2016;31:1383\u2013402.","journal-title":"Pediatr Nephrol"},{"key":"3252_CR46","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1053\/j.ajkd.2016.08.027","volume":"69","author":"EJ Hoorn","year":"2017","unstructured":"Hoorn EJ, Ellison DH. Diuretic resistance. Am J Kidney Dis. 2017;69:136\u201342.","journal-title":"Am J Kidney Dis"}],"container-title":["The Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-020-03252-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12098-020-03252-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-020-03252-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:12:10Z","timestamp":1666224730000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12098-020-03252-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,30]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["3252"],"URL":"https:\/\/doi.org\/10.1007\/s12098-020-03252-9","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,30]]},"assertion":[{"value":"31 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}